Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study

Author

Keywords

Anaphylactic reactions

Dipeptidyl peptidase-4 inhibitors

Glucagon-like peptide-1 receptor agonists

pharmacoepidemiology

Sodium-glucose cotransporter-2 inhibitors

Year of Publication

2022

Journal

Am J Epidemiol

ISBN Number

0002-9262

Accession Number

35136902

DOI

10.1093/aje/kwac021